Evidence map›Paper›PMID 30578627›Full record

ArticleJournal of biomedical optics2018

Detection of glycosaminoglycan loss in articular cartilage by fluorescence lifetime imaging.

Xiangnan Zhou, Anne K Haudenschild, Benjamin E Sherlock, Jerry C Hu, J Kent Leach, Kyriacos A Athanasiou, Laura Marcu

Open access · goldAbstract read
In one paragraph

Article in Journal of biomedical optics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xiangnan ZhouUniversity of California, Department of Biomedical Engineering, Davis, California, United States.
Anne K HaudenschildUniversity of California, Department of Biomedical Engineering, Davis, California, United States.
Benjamin E SherlockUniversity of California, Department of Biomedical Engineering, Davis, California, United States.
Jerry C HuUniversity of California, Department of Biomedical Engineering, Irvine, California, United States.
J Kent LeachUniversity of California, Department of Biomedical Engineering, Davis, California, United States.
Kyriacos A AthanasiouUniversity of California, Department of Biomedical Engineering, Irvine, California, United States.
Laura MarcuUniversity of California, Department of Biomedical Engineering, Davis, California, United States.
University of California, Davis · US

Funding

Bimodal platform for nondestructive analysis of engineered vascular biomaterialsR01HL121068 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI GRIFFITHS, LEIGH GARETH, MARCU, LAURA · 2015 to 2018
$1.5M
NHLBI NIH HHS R01 HL121068
6 · The paper itself

Abstract

Glycosaminoglycan (GAG) loss is an early marker of osteoarthritis, which is a clinical late stage disease that affects millions of people worldwide. The goal of our study was to evaluate the ability of a fiber-based fluorescence lifetime imaging (FLIm) technique to detect GAG loss in articular cartilage. Native bovine cartilage explants (n  =  20) were exposed to 0 (control), 0.5 (low), or 1  U  /  mL (high) concentrations of chondroitinase ABC (cABC) to create samples with different levels of GAG loss. FLIm assessment (excitation: 355 nm; detection: channel 1: 375 to 410 nm, channel 2: 450 to 485 nm, channel 3: 530 to 565 nm) was conducted on depth-resolved cross-sections of the cartilage sample. FLIm images, validated with histology, revealed that loss of GAG resulted in a decrease of fluorescence lifetime values in channel 2 (Δ  =  0.44  ns, p  <  0.05) and channel 3 (Δ  =  0.75  ns, p  <  0.01) compared to control samples (channel 2: 6.34 ns; channel 3: 5.22 ns). Fluorescence intensity ratio values were lower in channel 1 (37%, p  <  0.0001) and channel 2 (31% decrease, p  <  0.0001) and higher in channel 3 (23%, p  <  0.0001) relative to control samples. These results show that FLIm can detect the loss of GAG in articular cartilage and support further investigation into the feasibility of in vivo FLIm arthroscopy.

Indexed as

AnimalsCartilage, ArticularCattleGlycosaminoglycansOptical ImagingOsteoarthritisGlycosaminoglycansautofluorescencecartilagefluorescence lifetime spectroscopy and imagingglycosaminoglycanosteoarthritis

Identifiers

PMID30578627
PMCPMC8357192
OpenAlexW2905708077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.